Aminoverse B.V.
EMEA
Nuth
,
Netherlands
Startup
FOUNDED
2020
HEADCOUNT
21-100
FUNDING
Privately held
Keywords:
CRO, enzymes, AI/ML, biocatalysis, yeast, directed_evolution
BUSINESS
Enzyme-focused CRO combining wet lab and AI capabilities. Services include enzyme discovery, profiling, engineering, and custom production up to gram scale for APIs, agrochemicals, fragrances, and other applications. Privately funded and owned, no institutional or VC investment, focused on organic growth. Operates 200 m² ML-1/GMO certified wet lab. Clients across pharma, fine chemicals, flavors & fragrances, agrochemicals, and food. Collaboration with Prozomix (September 2025) providing access to 6,000+ native biocatalysts. Offers commercial biocatalyst panels including 200+ oxyfunctionalizing enzymes and immobilized lipase kits produced recombinantly in Pichia.
BIOTECH INVOLVEMENT
Core business is enzyme discovery, characterization, and engineering. EnzyMAP AI predicts fitness landscapes across entire enzyme sequences from wet lab data; EnzyREC AI predicts foldability of recombinatorial mutants. Team backgrounds span molecular biology, biochemistry, computational chemistry, ML, and fermentation.
TECHNOLOGY PLATFORM
NextGen Enzyme AI-volution; EnzyMAP AI-powered enzyme engineering platform
PRIMARY PRODUCTS
Enzyme R&D services including discovery, analysis, development, and custom production; unique collection of biocatalysts and products like immobilized lipase kit